Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism.

Nadeem A, Ahmad SF, Attia SM, Al-Ayadhi LY, Al-Harbi NO, Bakheet SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Oct 23;97:109783. doi: 10.1016/j.pnpbp.2019.109783. [Epub ahead of print]

PMID:
31655158
2.

Oral Rehabilitation of Hypodontia Patients Using an Endosseous Dental Implant: Functional and Aesthetic Results.

Attia S, Schaaf H, El Khassawna T, Malhan D, Mausbach K, Howaldt HP, Streckbein P.

J Clin Med. 2019 Oct 15;8(10). pii: E1687. doi: 10.3390/jcm8101687.

3.

The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4+ T cells, which are concomitant with the prevention of neuroimmune dysregulation in BTBR T+ Itpr3tf/J mice.

Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Alasmari F, Alasmari AF, Al-Kharashi LA, Al-Qahtani QH, Attia SM.

Life Sci. 2019 Nov 15;237:116930. doi: 10.1016/j.lfs.2019.116930. Epub 2019 Oct 11.

PMID:
31610190
4.

Update on Bartonella neuroretinitis.

Ksiaa I, Abroug N, Mahmoud A, Zina S, Hedayatfar A, Attia S, Khochtali S, Khairallah M.

J Curr Ophthalmol. 2019 May 6;31(3):254-261. doi: 10.1016/j.joco.2019.03.005. eCollection 2019 Sep. Review.

5.

The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T+ Itpr3tf/J mice exposed to gamma rays.

Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Al-Mazroua HA, Khan MR, Alasmari AF, Alanazi WA, As Sobeai HM, Attia SM.

Mol Immunol. 2019 Oct;114:561-570. doi: 10.1016/j.molimm.2019.09.007. Epub 2019 Sep 12.

PMID:
31522074
6.

Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy.

Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Siddiqui N, Al-Harbi MM, Attia SM, Bakheet SA.

Pharmacol Res. 2019 Oct;148:104441. doi: 10.1016/j.phrs.2019.104441. Epub 2019 Sep 7.

PMID:
31505252
7.

Three-dimensional camera anthropometry to assess risk of cephalopelvic disproportion-related obstructed labour in Ethiopia.

Tolentino L, Yigeremu M, Teklu S, Attia S, Weiler M, Frank N, Dixon JB, Gleason RL Jr.

Interface Focus. 2019 Oct 6;9(5):20190036. doi: 10.1098/rsfs.2019.0036. Epub 2019 Aug 16.

PMID:
31485318
8.

CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance.

Bakheet SA, Ansari MA, Nadeem A, Attia SM, Alhoshani AR, Gul G, Al-Qahtani QH, Albekairi NA, Ibrahim KE, Ahmad SF.

Cell Signal. 2019 Dec;64:109395. doi: 10.1016/j.cellsig.2019.109395. Epub 2019 Aug 23.

PMID:
31449849
9.

Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.

Elnaggar MH, Abushouk AI, Hassan AHE, Lamloum HM, Benmelouka A, Moatamed SA, Abd-Elmegeed H, Attia S, Samir A, Amr N, Johar D, Zaky S.

Semin Cancer Biol. 2019 Aug 14. pii: S1044-579X(19)30225-1. doi: 10.1016/j.semcancer.2019.08.016. [Epub ahead of print] Review.

PMID:
31421265
10.

Evaluation of Implant Success in Patients with Dental Aplasia.

Attia S, Schaper E, Schaaf H, Pons-Kühnemann J, Schlenz MA, Streckbein P, Böttger S, Howaldt HP, Wilbrand JF.

Biomed Res Int. 2019 Jun 19;2019:1680158. doi: 10.1155/2019/1680158. eCollection 2019.

11.

The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf/J mouse model of autism.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alanazi AZ, Alsanea S, As Sobeai HM, Almutairi MM, Mahmood HM, Attia SM.

Brain Res Bull. 2019 Oct;152:27-34. doi: 10.1016/j.brainresbull.2019.07.006. Epub 2019 Jul 9.

PMID:
31299319
12.

Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes.

Deeb A, Yousef H, Al Qahtani N, Artan I, Suliman S, Tomy M, Abdulrahman L, Al Suwaidi H, Attia S, Nagelkerke N.

J Diabetes Metab Disord. 2019 May 9;18(1):1-6. doi: 10.1007/s40200-018-0351-9. eCollection 2019 Jun.

13.

Incidence and Management of Olaratumab Infusion-Related Reactions.

Van Tine BA, Govindarajan R, Attia S, Somaiah N, Barker SS, Shahir A, Barrett E, Lee P, Wacheck V, Ramage SC, Tap WD.

J Oncol Pract. 2019 Nov;15(11):e925-e933. doi: 10.1200/JOP.18.00761. Epub 2019 Jul 3.

PMID:
31268811
14.

Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma.

Attia S, Atwan N, Arafa M, Shahin RA.

Pathologica. 2019 Mar;111(1):18-23. doi: 10.32074/1591-951X-51-18.

PMID:
31217618
15.

[Eye and Behçet's disease].

Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M.

J Fr Ophtalmol. 2019 Jun;42(6):626-641. doi: 10.1016/j.jfo.2018.09.027. Epub 2019 Jun 1. Review. French.

PMID:
31164292
16.

Molecular beam/infrared reflection-absorption spectroscopy apparatus for probing heterogeneously catalyzed reactions on functionalized and nanostructured model surfaces.

Attia S, Spadafora EJ, Hartmann J, Freund HJ, Schauermann S.

Rev Sci Instrum. 2019 May;90(5):053903. doi: 10.1063/1.5093487.

PMID:
31153295
17.

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

Younger E, Ballman K, Lu Y, Pápai Z, Van Tine BA, Attia S, Schöffski P, Reinke D, Tap WD, Jones RL.

J Geriatr Oncol. 2019 May 22. pii: S1879-4068(18)30464-8. doi: 10.1016/j.jgo.2019.05.008. [Epub ahead of print]

PMID:
31126845
18.

Swept source-OCT and swept source-OCT angiography findings in posterior microphthalmos.

Abroug N, Ksiaa I, Lupidi M, Nabi W, Attia S, Jelliti B, Khochtali S, Khairallah M.

Int Ophthalmol. 2019 May 10. doi: 10.1007/s10792-019-01115-7. [Epub ahead of print]

PMID:
31077022
19.

Plant defensins: types, mechanism of action and prospects of genetic engineering for enhanced disease resistance in plants.

Sher Khan R, Iqbal A, Malak R, Shehryar K, Attia S, Ahmed T, Ali Khan M, Arif M, Mii M.

3 Biotech. 2019 May;9(5):192. doi: 10.1007/s13205-019-1725-5. Epub 2019 Apr 29. Review.

PMID:
31065492
20.

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

Jones RL, Chawla SP, Attia S, Schöffski P, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG.

Cancer. 2019 Jul 15;125(14):2445-2454. doi: 10.1002/cncr.32084. Epub 2019 Apr 29.

21.

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

Davis LE, Bolejack V, Ryan CW, Ganjoo KN, Loggers ET, Chawla S, Agulnik M, Livingston MB, Reed D, Keedy V, Rushing D, Okuno S, Reinke DK, Riedel RF, Attia S, Mascarenhas L, Maki RG.

J Clin Oncol. 2019 Jun 1;37(16):1424-1431. doi: 10.1200/JCO.18.02374. Epub 2019 Apr 23.

PMID:
31013172
22.

Genetic and epigenetic alterations induced by the small-molecule panobinostat: A mechanistic study at the chromosome and gene levels.

Al-Hamamah MA, Alotaibi MR, Ahmad SF, Ansari MA, Attia MSM, Nadeem A, Bakheet SA, As Sobeai HM, Attia SM.

DNA Repair (Amst). 2019 Jun;78:70-80. doi: 10.1016/j.dnarep.2019.03.008. Epub 2019 Mar 23.

PMID:
30978576
23.

Assessment of DNA repair efficiency in the inbred BTBR T+tf/J autism spectrum disorder mouse model exposed to gamma rays and treated with JNJ7777120.

Al-Mazroua HA, Alomar HA, Ahmad SF, Attia MSA, Nadeem A, Bakheet SA, Alsaad AMS, Alotaibi MR, Attia SM.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:189-196. doi: 10.1016/j.pnpbp.2019.04.003. Epub 2019 Apr 5.

PMID:
30959085
24.

Protease activated receptor-2 mediated upregulation of IL-17 receptor signaling on airway epithelial cells is responsible for neutrophilic infiltration during acute exposure of house dust mite allergens in mice.

Nadeem A, Al-Harbi NO, Ahmad SF, Ibrahim KE, Alotaibi MR, Siddiqui N, Alsharari SD, Attia SM, Al-Harbi MM.

Chem Biol Interact. 2019 May 1;304:52-60. doi: 10.1016/j.cbi.2019.03.001. Epub 2019 Mar 7.

PMID:
30853428
25.

Eye and Behçet's disease.

Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M.

J Fr Ophtalmol. 2019 Apr;42(4):e133-e146. doi: 10.1016/j.jfo.2019.02.002. Epub 2019 Mar 5. Review.

PMID:
30850197
26.

Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.

Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Ibrahim KE, Alqahtani F, Alqinyah M.

Behav Brain Res. 2019 May 17;364:213-224. doi: 10.1016/j.bbr.2019.02.031. Epub 2019 Feb 19.

PMID:
30790585
27.

Functional and aesthetic treatment outcomes after immediate jaw reconstruction using a fibula flap and dental implants.

Attia S, Wiltfang J, Streckbein P, Wilbrand JF, El Khassawna T, Mausbach K, Howaldt HP, Schaaf H.

J Craniomaxillofac Surg. 2019 May;47(5):786-791. doi: 10.1016/j.jcms.2018.12.017. Epub 2019 Jan 3.

PMID:
30733133
28.

DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T+ Itpr3tf/J mice.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alotaibi MR, Alasmari AF, Alshammari MA, Al-Mazroua HA, Attia SM.

Eur J Pharmacol. 2019 Mar 5;846:100-108. doi: 10.1016/j.ejphar.2019.01.016. Epub 2019 Jan 15.

PMID:
30658114
29.

Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and γδ T cells respectively in mice.

Nadeem A, Ahmad SF, Al-Harbi NO, Al-Harbi MM, Ibrahim KE, Kundu S, Attia SM, Alanazi WA, AlSharari SD.

Int Immunopharmacol. 2019 Mar;68:39-47. doi: 10.1016/j.intimp.2018.12.062. Epub 2019 Jan 2.

PMID:
30611000
30.

Impact of nasalis muscle repair in unilateral cleft lip patients.

Attia SA, Helal HA, El Barabary AS, Awad MA, Sherif MM.

J Craniomaxillofac Surg. 2019 Feb;47(2):255-262. doi: 10.1016/j.jcms.2018.11.030. Epub 2018 Dec 5.

PMID:
30591393
31.

Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alotaibi MR, Alhoshani AR, Alshammari MA, Attia SM.

Mol Immunol. 2019 Feb;106:77-86. doi: 10.1016/j.molimm.2018.12.020. Epub 2018 Dec 24.

PMID:
30590210
32.

Sorafenib for Advanced and Refractory Desmoid Tumors.

Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK.

N Engl J Med. 2018 Dec 20;379(25):2417-2428. doi: 10.1056/NEJMoa1805052.

33.

Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: Role of IL-17A receptor signaling.

Nadeem A, Ahmad SF, Attia SM, Al-Ayadhi LY, Bakheet SA, Al-Harbi NO.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:204-211. doi: 10.1016/j.pnpbp.2018.12.002. Epub 2018 Dec 6.

PMID:
30529000
34.

Elevated IL-16 expression is associated with development of immune dysfunction in children with autism.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Attia SM.

Psychopharmacology (Berl). 2019 Feb;236(2):831-838. doi: 10.1007/s00213-018-5120-4. Epub 2018 Nov 19.

PMID:
30456538
35.

Maternal attitude towards delaying puberty in girls with and without a disability: a questionnaire-based study from the United Arab Emirates.

Deeb A, Akle M, Al Zaabi A, Siwji Z, Attia S, Al Suwaidi H, Al Qahtani N, Ehtisham S.

BMJ Paediatr Open. 2018 Oct 9;2(1):e000306. doi: 10.1136/bmjpo-2018-000306. eCollection 2018.

36.

Atypical white dot syndrome with choriocapillaris ischemia in a patient with latent tuberculosis.

Khochtali S, Abroug N, Ksiaa I, Zina S, Attia S, Khairallah M.

J Ophthalmic Inflamm Infect. 2018 Nov 3;8(1):20. doi: 10.1186/s12348-018-0162-7.

37.

Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alotaibi MR, Alhoshani AR, Al-Hosaini KA, Attia SM.

Int Immunopharmacol. 2018 Dec;65:360-365. doi: 10.1016/j.intimp.2018.10.027. Epub 2018 Oct 26.

PMID:
30380510
38.

Acute multifocal retinitis: a retrospective review of 35 cases.

Khochtali S, Gargouri S, Zina S, Ksiaa I, Abroug N, Zaouali S, Jelliti B, Attia S, Khairallah M.

J Ophthalmic Inflamm Infect. 2018 Oct 17;8(1):18. doi: 10.1186/s12348-018-0160-9.

39.

Surface-Driven Keto-Enol Tautomerization: Atomistic Insights into Enol Formation and Stabilization Mechanisms.

Attia S, Schmidt MC, Schröder C, Pessier P, Schauermann S.

Angew Chem Int Ed Engl. 2018 Dec 17;57(51):16659-16664. doi: 10.1002/anie.201808453. Epub 2018 Nov 25.

PMID:
30311717
40.

Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T + tf/J mice.

Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Alshammari MA, Alzahrani KS, Bakheet SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:245-253. doi: 10.1016/j.pnpbp.2018.09.012. Epub 2018 Sep 25.

PMID:
30261217
41.

The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.

Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Alshammari MA, Attia SM.

Neurochem Int. 2018 Nov;120:251-261. doi: 10.1016/j.neuint.2018.09.006. Epub 2018 Sep 15.

PMID:
30227151
42.

A safe, low-cost, easy-to-use 3D camera platform to assess risk of obstructed labor due to cephalopelvic disproportion.

Gleason RL Jr, Yigeremu M, Debebe T, Teklu S, Zewdeneh D, Weiler M, Frank N, Tolentino L, Attia S, Dixon JB, Kwon C, Pokutta-Paskaleva A, Gleason KA.

PLoS One. 2018 Sep 14;13(9):e0203865. doi: 10.1371/journal.pone.0203865. eCollection 2018.

43.

S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T+ Itpr3tf/J mice.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alshammari MA, Khan MR, Alsaad AMS, Attia SM.

Cell Signal. 2018 Dec;52:127-136. doi: 10.1016/j.cellsig.2018.09.006. Epub 2018 Sep 10.

PMID:
30213685
44.

Occurrence of Hypothyroidism, Diabetes Mellitus, and Celiac Disease in Emirati Children with Down's Syndrome.

Abdulrazzaq Y, El-Azzabi TI, Al Hamad SM, Attia S, Deeb A, Aburawi EH.

Oman Med J. 2018 Sep;33(5):387-392. doi: 10.5001/omj.2018.72.

45.

Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alshammari MA, Attia SM.

Brain Res Bull. 2018 Sep;142:328-337. doi: 10.1016/j.brainresbull.2018.08.020. Epub 2018 Aug 30.

PMID:
30172736
46.

Dysregulated enzymatic antioxidant network in peripheral neutrophils and monocytes in children with autism.

Nadeem A, Ahmad SF, Attia SM, Al-Ayadhi LY, Al-Harbi NO, Bakheet SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:352-359. doi: 10.1016/j.pnpbp.2018.08.020. Epub 2018 Aug 23.

PMID:
30145184
47.

The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions.

Bagaria SP, Neville M, Gray RJ, Gabriel E, Ashman JB, Attia S, Wasif N.

Sarcoma. 2018 Jul 24;2018:3056562. doi: 10.1155/2018/3056562. eCollection 2018.

48.

Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children.

Deeb A, Attia S, Mahmoud S, Elhaj G, Elfatih A.

J Obes. 2018 Jun 12;2018:8626818. doi: 10.1155/2018/8626818. eCollection 2018.

49.

Growing Role of Regorafenib in the Treatment of Patients with Sarcoma.

Agulnik M, Attia S.

Target Oncol. 2018 Aug;13(4):417-422. doi: 10.1007/s11523-018-0575-0. Review.

PMID:
29931504
50.

Survival of dental implants placed in vascularised fibula free flaps after jaw reconstruction.

Attia S, Wiltfang J, Pons-Kühnemann J, Wilbrand JF, Streckbein P, Kähling C, Howaldt HP, Schaaf H.

J Craniomaxillofac Surg. 2018 Aug;46(8):1205-1210. doi: 10.1016/j.jcms.2018.05.008. Epub 2018 Jun 5.

PMID:
29884312

Supplemental Content

Support Center